EXAS Stock Earnings: Exact Sciences Beats EPS, Revenue Estimates

Stock Market

Exact Sciences (NASDAQ:EXAS) reported results for the first quarter of 2023.

  • Exact Sciences reported a loss per share of 42 cents. That is much better than the analyst estimate for a loss of 75 cents per share.
  • The company reported revenue of $602.45 million.
  • This represents 10.8% positive surprise against the analyst estimate of $543.46 million.
  • You can read the full Exact Sciences press release here.

On the date of publication, Sarah Smith did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

Sarah Smith is the Editor-in-Chief of InvestorPlace.com.

Articles You May Like

Steer Clear of Lucid Stock Even as Big Players Make Bold Bets
3 AI Stocks That Could 10X Your Money in 10 Years
3 Battery Stocks That Could Skyrocket in the Next 12 Months
3 Solar Stocks to Buy Now or Regret Missing the Next Big Boom
3 Edge Computing Stocks That Could Skyrocket in the Next 12 Months